Lv41
774 积分 2020-08-12 加入
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations
19天前
已完结
延胡索酸水合酶缺陷型肾细胞癌临床诊治共识
1个月前
已完结
[Expert consensus on ensartinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer]
1个月前
已完结
[Expert consensus on ensartinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer]
1个月前
已完结
Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer
1个月前
已完结
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
1个月前
已完结
Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model
1个月前
已完结
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant nonsmall cell lung cancer with brain metastasis
2个月前
已完结
Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer
2个月前
已完结
糖尿病患者生命质量测定量表QLICD--DM(V2.0)的研制及其初步临床应用
2个月前
已完结
皖公网安备34019202002308
